Citation Impact
Citing Papers
In situ quantitation of inflammatory mononuclear cells in ductal infiltrating breast carcinoma. Relation to prognostic parameters.
1987
Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer
1999 Standout
Breast cancer
2019 Standout
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement
2015 Standout
Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ
2016
Best practice in forensic entomology—standards and guidelines
2006 Standout
Estrogen Receptors and Distinct Patterns of Breast Cancer Relapse
2003
Guidelines for a genetic risk based approach to advising women with a family history of breast cancer
2000
Mammographic Density and the Risk and Detection of Breast Cancer
2007 Standout
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement
2015 Standout
Ki67 immunostaining in primary breast cancer: pathological and clinical associations
1989
Confirmation of a prognostic index in primary breast cancer
1987
pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up
1991 Standout
Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review
2012 Standout
Breast cancer screening: the questions answered
2012
Natural products: An evolving role in future drug discovery
2011 Standout
The benefits and harms of breast cancer screening: an independent review
2013
High Performance of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography and Contrast-Enhanced CT in a Rapid Outpatient Diagnostic Program for Patients with Suspected Lung Cancer
2013 Standout
Class-imbalanced classifiers for high-dimensional data
2012
Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide
2008
Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long‐term follow‐up
1994
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial
2015
Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy
2007
Effectively nursing patients receiving aromatase inhibitor therapy
2008
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study
2013 Standout
Improving Breast Cancer Surgery: A Classification and Quadrant per Quadrant Atlas for Oncoplastic Surgery
2010 Standout
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Pathological prognostic factors in breast cancer
1999 Standout
Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial
2010
Quality control in breast cancer surgery
2005
Hormone receptors in malignancy
1992
Cognitive effects of chemotherapy in post‐menopausal breast cancer patients 1 year after treatment
2008
Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma in Situ
2016
Calculating the sample size required for developing a clinical prediction model
2020 Standout
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Protein kinase C and other diacylglycerol effectors in cancer
2007
Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer
1992
The Ki-67 protein: From the known and the unknown
2000 Standout
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement
2015 Standout
Magnetic resonance imaging as a diagnostic tool for breast cancer in premenopausal women
2005
The future of breast surgery: a new subspecialty of oncoplastic breast surgeons?
2003
Assessing the Effects of Physician-Patient Interactions on the Outcomes of Chronic Disease
1989 Standout
Methylated circulating tumor DNA in blood: power in cancer prognosis and response
2016
Breast cancer metastasis: markers and models
2005 Standout
An insight into classification with imbalanced data: Empirical results and current trends on using data intrinsic characteristics
2013 Standout
Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival
1995
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
2009 Standout
The biological correlates of psychological responses to breast cancer
1981
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
The predictive value of estrogen and progesterone receptors' concentrations on the clinical behavior of breast cancer in women °clinical correlation on 547 patients
1986
Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia
1997 Standout
The Steroid and Thyroid Hormone Receptor Superfamily
1988 StandoutScience
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement
2016 Standout
Prognostic significance of the DNA content of human breast cancer
1987
Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer.
1990
Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer.
1984
Immunohistologic localization of estrogen receptors in breast cancer with monoclonal antibodies. Correlation with biochemistry and clinical endocrine response
1985
Costs and benefits of a one stop clinic compared with a dedicated breast clinic: randomised controlled trial * Commentary: one stop clinics should not be abandoned
2002
The prediction of local or regional recurrence after simple mastectomy for operable breast cancer
1985
Significance of estrogen and progesterone receptors, disease-free interval, and site of first metastasis on survival of breast cancer patients
1985
Steroid Hormone Receptors in Human Breast Cancer
1983
Immunocytochemical localization of estrogen receptor in human breast tissue.
1988
The Protein Kinase C Agonist PEP005 (Ingenol 3-Angelate) in the Treatment of Human Cancer: A Balance between Efficacy and Toxicity
2010
A prognostic index in primary breast cancer
1982
The association of cytosol oestrogen and progesterone receptors with histological features of breast cancer and early recurrence of disease
1983
SMOTE for Learning from Imbalanced Data: Progress and Challenges, Marking the 15-year Anniversary
2018 Standout
Euphorbia Diterpenes: Isolation, Structure, Biological Activity, and Synthesis (2008–2012)
2014 Standout
Tamoxifen for early breast cancer: an overview of the randomised trials
1998 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement
2015 Standout
Adherence to Oral Endocrine Therapy for Breast Cancer: A Nursing Perspective
2008
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
2012 Standout
Oestrogen receptors in breast tumours: associations with age, menopausal status and epidemiological and clinical features in 735 patients
1980
Metastatic Behavior of Breast Cancer Subtypes
2010 Standout
Hydrogen Sulfide Mediates Cardioprotection Through Nrf2 Signaling
2009 Standout
Works of H Bishop being referenced
A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer
2006
Radiotherapy following breast-conserving surgery for screen-detected ductal carcinoma in situ: indications and utilisation in the UK. Interim findings from the Sloane Project
2007
Lesion size is a major determinant of the mammographic features of ductal carcinoma in situ: findings from the Sloane project
2010
A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial
2010
Protein kinase C alpha expression in normal breast, ductal carcinoma in situ and invasive ductal carcinoma
2004
The British Association of Surgical Oncology Guidelines for surgeons in the management of symptomatic breast disease in the UK (1998 revision)
1998
RELATIONSHIP OF ŒSTROGEN-RECEPTOR STATUS TO SURVIVAL IN BREAST CANCER
1979
Relationship between primary breast tumor receptor status and patient survival
1980
Carcinoma of the breast imaged by nuclear magnetic resonance (NMR)
1979